Reyhaneh Shakibi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Reyhaneh Shakibi has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Hamed Abadijoo
Nano Electronic Center of Excellence, Nano Bio Electronic Devices Lab, School of Electrical and Computer Engineering, College of Engineering, University of Tehran, Tehran 14399-57131, Iran
3 shared publications - Hossein Simaee
Nano Electronic Center of Excellence, Nano Bio Electronic Devices Lab, School of Electrical and Computer Engineering, College of Engineering, University of Tehran, Tehran 14399-57131, Iran
3 shared publications - Mohammad Abdolahad
Nano Bioelectronics Devices Lab, Cancer Electronics Research Group, School of Electrical and Computer Engineering, Faculty of Engineering, University of Tehran, Tehran 1439957131, Iran
3 shared publications - Mohammad Ali Khayamian
Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
3 shared publications - Ali Akbar Moosavi-Movahedi
Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran
2 shared publications - Ali Khatibi
Department of Biotechnology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Elsevier in Materials Today Communications
- Vol. 57
Injectable platforms for non-cancerous tissue ablation: A review of ionic liquids, gel-based systems, hydrogels and nanoparticles sensitizer
- 12 October 2026
- Published by Elsevier in Materials Today Communications
- Vol. 57
Open AccessInjectable platforms for non-cancerous tissue ablation: A review of ionic liquids, gel-based systems, hydrogels and nanoparticles sensitizer
- Open Access
- 31 March 2025
- Published by Cambridge University Press (CUP) in Quarterly Reviews of Biophysics
- Vol. 58, e11
From resting potential to dynamics: advances in membrane voltage indicators and imaging techniques – ERRATUM
- 31 March 2025
- Published by Cambridge University Press (CUP) in Quarterly Reviews of Biophysics
- Vol. 58, e11
Open AccessFrom resting potential to dynamics: advances in membrane voltage indicators and imaging techniques – ERRATUM
- 16 January 2025
- Published by Cambridge University Press (CUP) in Quarterly Reviews of Biophysics
- Vol. 58, 1-109
From resting potential to dynamics: advances in membrane voltage indicators and imaging techniques
The membrane potential is a critical aspect of cellular physiology, essential for maintaining homeostasis, facilitating signal transduction, and driving various cellular processes. While the resting membrane potential (RMP) represents a key physiological parameter, membrane potential fluctuations, such as depolarization and hyperpolarization, are equally vital in understanding dynamic cellular behavior. Traditional techniques, such as microelectrodes and patch-clamp methods, offer valuable insights but are invasive and less suited for high-throughput applications. Recent advances in voltage indicators, including fast and slow dyes, and novel imaging modalities such as second harmonic generation (SHG) and photoacoustic imaging, enable noninvasive, high-resolution measurement of both RMP and membrane potential dynamics. This review explores the mechanisms, development, and applications of these tools, emphasizing their transformative potential in neuroscience and cellular electrophysiology research.
- 16 January 2025
- Published by Cambridge University Press (CUP) in Quarterly Reviews of Biophysics
- Vol. 58, 1-109
From resting potential to dynamics: advances in membrane voltage indicators and imaging techniques
The membrane potential is a critical aspect of cellular physiology, essential for maintaining homeostasis, facilitating signal transduction, and driving various cellular processes. While the resting membrane potential (RMP) represents a key physiological parameter, membrane potential fluctuations, such as depolarization and hyperpolarization, are equally vital in understanding dynamic cellular behavior. Traditional techniques, such as microelectrodes and patch-clamp methods, offer valuable insights but are invasive and less suited for high-throughput applications. Recent advances in voltage indicators, including fast and slow dyes, and novel imaging modalities such as second harmonic generation (SHG) and photoacoustic imaging, enable noninvasive, high-resolution measurement of both RMP and membrane potential dynamics. This review explores the mechanisms, development, and applications of these tools, emphasizing their transformative potential in neuroscience and cellular electrophysiology research.
- 6 May 2023
- Published by Elsevier in Nano Energy
- Vol. 112, 108510
Irreversible electroporation for post-operative margin therapy to prevent cancer recurrence based on triboelectric nanogenerator driven balloon catheter
- 6 May 2023
- Published by Elsevier in Nano Energy
- Vol. 112, 108510
Irreversible electroporation for post-operative margin therapy to prevent cancer recurrence based on triboelectric nanogenerator driven balloon catheter
- Open Access
- 1 January 2014
- Published by S. Karger AG in Chemotherapy
- Vol. 60 (5-6)
Contents Vol. 60, 2014
- 1 January 2014
- Published by S. Karger AG in Chemotherapy
- Vol. 60 (5-6)
Open AccessContents Vol. 60, 2014
- 1 January 2014
- Published by S. Karger AG in Chemotherapy
- Vol. 60 (5-6) , 279-287
Prevalence of the UGT1A1*6 (c.211G>A) Polymorphism and Prediction of Irinotecan Toxicity in Iranian Populations of Different Ethnicities
Background: Pharmacogenetic studies on irinotecan treatment in patients with metastatic colorectal cancer have indicated that genetic polymorphisms in UGT1A1*6 can lead to decreased enzyme activity and accumulation of the toxic metabolite SN-38. Here, we compared the prevalence of UGT1A1*6 in an Iranian population of different ethnicities with those of other populations. Materials and Methods: A total of 300 healthy people of different ethnic groups including Persian, Azari, Lure, Kurdish, Arab, Baluch and Caspian in the Iranian population were enrolled. Genotyping of the UGT1A1*6 alleles (G/G, A/G, A/A) was performed by polymerase chain reaction-restriction fragment length polymorphism and direct genomic DNA sequencing. Result: The most predictive genotype among the Iranian ethnic groups, especially Persian, was the G/G genotype (wild-type genotype). The frequency of the A/G genotype among the Persian, Azari, Lure, Kurdish, Arab, Baluch and Caspian ethnicities were 15.69% (n = 27), 11.11% (n = 8), 5.88% (n = 1), 9.09% (n = 1), 10% (n = 1), 20% (n = 1) and 0% (n = 0), respectively. Only one person with Persian ethnicity was homozygous for the mutation in UGT1A1*6 (0.58%). Additionally, the frequency of the A and G alleles in Iranians was 6.83 and 93.16%, respectively. Conclusion: The identification of the UGT1A1*6 alleles is necessary among the different Iranian ethnic groups before irinotecan therapy, suggesting that genotyping would be helpful for clinicians to optimize chemotherapy or identify individuals at risk of adverse drug reactions before clinical trials.
- 1 January 2014
- Published by S. Karger AG in Chemotherapy
- Vol. 60 (5-6) , 279-287
Prevalence of the UGT1A1*6 (c.211G>A) Polymorphism and Prediction of Irinotecan Toxicity in Iranian Populations of Different Ethnicities
Background: Pharmacogenetic studies on irinotecan treatment in patients with metastatic colorectal cancer have indicated that genetic polymorphisms in UGT1A1*6 can lead to decreased enzyme activity and accumulation of the toxic metabolite SN-38. Here, we compared the prevalence of UGT1A1*6 in an Iranian population of different ethnicities with those of other populations. Materials and Methods: A total of 300 healthy people of different ethnic groups including Persian, Azari, Lure, Kurdish, Arab, Baluch and Caspian in the Iranian population were enrolled. Genotyping of the UGT1A1*6 alleles (G/G, A/G, A/A) was performed by polymerase chain reaction-restriction fragment length polymorphism and direct genomic DNA sequencing. Result: The most predictive genotype among the Iranian ethnic groups, especially Persian, was the G/G genotype (wild-type genotype). The frequency of the A/G genotype among the Persian, Azari, Lure, Kurdish, Arab, Baluch and Caspian ethnicities were 15.69% (n = 27), 11.11% (n = 8), 5.88% (n = 1), 9.09% (n = 1), 10% (n = 1), 20% (n = 1) and 0% (n = 0), respectively. Only one person with Persian ethnicity was homozygous for the mutation in UGT1A1*6 (0.58%). Additionally, the frequency of the A and G alleles in Iranians was 6.83 and 93.16%, respectively. Conclusion: The identification of the UGT1A1*6 alleles is necessary among the different Iranian ethnic groups before irinotecan therapy, suggesting that genotyping would be helpful for clinicians to optimize chemotherapy or identify individuals at risk of adverse drug reactions before clinical trials.